期刊文献+

Effects of Saccharomycesboulardiion fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition 被引量:30

Effects of Saccharomycesboulardiion fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition
在线阅读 下载PDF
导出
摘要 AIM: To assess the effects of Sb on fecal flora and shortchain fatty acids (SCFA) in patients on long-term TEN. METHODS: Ten patients (3 females, 7 males, 59±5.5 years), on TEN for a median of 13 mo (1-125), and 15 healthy volunteers (4 females, 11 males, 32±2.0 years) received Sb (0.5 g bid PO) for 6 d. Two stool samples were taken before, on the last 2 d and 9-10 d after treatment, for SCFA measurement and for culture and bacterial identification. Values (mean4-SE) were compared using sign tests and ANOVA. RESULTS: Fecal butyrate levels were lower in patients (10.1±2.9 mmol/kg) than in controls (19.2±3.9, P= 0.02). Treatment with Sb increased total fecal SCFA levels in patients (150.2+27.2 vs 107.5±18.2 mmol/kg, P= 0.02) but not in controls (129.0±28.6 vs 113.0±15.2 mmol/kg, NS). At the end of treatment with Sb, patients had higher fecal butyrate(16.0±4.4 vs 10.1 [2.9] mmol/kg, P= 0.004). Total SCFAs remained high 9 d after treatment was discontinued. Before the treatment, the anaerobe to aerobe ratio was lower in patients compared to controls (2.4±2.3 vs 69.8±1.8, P= 0.003). There were no significant changes in the fecal flora of TEN patients. CONCLUSION: Sb-induced increase of fecal SCFA concentrations (especially butyrate) may explain the preventive effects of this yeast on TEN-induced diarrhea. AIM: To assess the effects of Sb on fecal flora and shortchain fatty acids (SCFA) in patients on long-term TEN.METHODS: Ten patients (3 females, 7 males, 59±5.5 years),on TEN for a median of 13 mo (1-125), and 15 healthy volunteers (4 females, 11 males, 32±2.0 years) received Sb (0.5 g bid PO) for 6 d. Two stool samples were taken before, on the last 2 d and 9-10 d after treatment, for SCFA measurement and for culture and bacterial identification.Values (mean±SE) were compared using sign tests and ANOVA.RESULTS: Fecal butyrate levels were lower in patients(10.1±2.9 mmol/kg) than in controls (19.2±3.9, P= 0.02).Treatment with Sb increased total fecal SCFA levels in patients (150.2±27.2 vs 107.5±18.2 mmol/kg, P = 0.02)but not in controls (129.0±28.6 vs 113.0±15.2 mmol/kg,NS). At the end of treatment with Sb, patients had higher fecal butyrate (16.0±4.4 vs 10.1 [2.9] mmol/kg, P = 0.004).Total SCFAs remained high 9 d after treatment was discontinued. Before the treatment, the anaerobe to aerobe ratio was lower in patients compared to controls (2.4±2.3 vs69.8±1.8, P = 0.003). There were no significant changes in the fecal flora of TEN patients.CONCLUSION: Sb-induced increase of fecal SCFA concentrations (especially butyrate) may explain the preventive effects of this yeast on TEN-induced diarrhea.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第39期6165-6169,共5页 世界胃肠病学杂志(英文版)
基金 Supported by a research grant from Laboratoires Biocodex,Montrouge, France, EU
关键词 Enteral nutrition DIARRHEA Saccharomyces boulardii Short-chain fatty acids Intestinal microbiota 酵母 脂肪酸 肠内营养 腹泻
作者简介 Dr. Stéphane M Schneider, Department of Gastroenterology and Clinical Nutrition, Archet University Hospital, BP 3079, F-06202 Nice Cedex 3, France. stephane.schneider@unice.fr
  • 相关文献

参考文献15

  • 1S.M. Schneider,P. Le Gall,F. Girard-Pipau,T. Piche,A. Pompei,J.-L. Nano,X. Hébuterne,P. Rampal.Total artificial nutrition is associated with major changes in the fecal flora[J].European Journal of Nutrition.2000(6)
  • 2Mario Guslandi,Gianni Mezzi,Massimo Sorghi,Pier Alberto Testoni.Saccharomyces boulardii in Maintenance Treatment of Crohn’s Disease[J].Digestive Diseases and Sciences.2000(7)
  • 3G. Bleichner,H. Bléhaut,H. Mentec,D. Moyse.Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients[J].Intensive Care Medicine.1997(5)
  • 4S. Adam,S. Batson.A study of problems associated with the delivery of enteral feed in critically ill patients in five ICUs in the UK[J].Intensive Care Medicine.1997(3)
  • 5G. W. Welling Ph. D.,Geke J. Meijer-Severs M. S.,Gé Helmus,Edith Santen,R. H. J. Tonk,Hilly G. Vries- Hospers M. D., Ph. D.,D. Waaij M. D., Ph. D.The effect of ceftriaxone on the anaerobic bacterial flora and the bacterial enzymatic activity in the intestinal tract[J].Infection.1991(5)
  • 6Rolfe RD.Role of volatile fatty acids in colonization resistance to Clostridium difficile[].Infection and Immunity.1984
  • 7Meijer-Severs GJ,Van Santen E,Meijer BC.Short-chain fatty acid and organic acid concentrations in feces of healthy human volunteers and their correlations with anaerobe cultural counts during systemic ceftriaxone administration[].Scandinavian Journal of Gastroenterology.1990
  • 8Weaver GA,Krause JA,Miller TL,Wolin MJ.Short chain fatty acid distributions of enema samples from a sigmoidoscopy population: an association of high acetate and low butyrate ratios with adenomatous polyps and colon cancer[].Gut.1988
  • 9Cummings JH,Macfarlane GT.Role of intestinal bacteria in nutrient metabolism[].Clinical Nutrition.1997
  • 10Hopkins M,Sharp R,Macfarlane G.Age and disease-related changes in intestinal bacterial populations assessed by cell culture, 16S-rRNA abundance, and community cellular fatty acid profiles[].Gut.2001

同被引文献251

引证文献30

二级引证文献266

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部